Related Experiment Video

Updated: Aug 5, 2025

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.2K

Hydrazinocurcumin Induced Autophagy and Affected Cell Proliferation by Downregulating the JAK/STAT3 Signaling Pathway

Qifen Mao1, Xufen Xia1, Hongbin Luo2

  • 1Department of Clinical Laboratory, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, 310012, China.

Advanced Biology
|March 29, 2023
PubMed

Insights

Hydrazinocurcumin (HC) inhibits the JAK/STAT3 pathway, increasing autophagy and apoptosis while decreasing proliferation in A431 cells. This study reveals HC

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Autophagy plays a complex role in cancer, influencing cell survival and death.
  • The Janus kinase (JAK)/Signal Transducer and Activator of Transcription (STAT) signaling pathway is frequently dysregulated in cancer.
  • Understanding how compounds modulate these pathways is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the mechanism of hydrazinocurcumin (HC) in A431 cells.
  • To determine HC's effect on autophagy and the JAK/STAT3 signaling pathway.
  • To explore HC's impact on A431 cell proliferation and apoptosis.

Main Methods:

  • A431 cells were treated with varying concentrations of hydrazinocurcumin (HC).
  • Cell proliferation and apoptosis were assessed.
  • Real-time quantitative PCR and double immunofluorescence staining were employed.
  • LC3 and STAT3 protein localization was analyzed using laser confocal microscopy.

Main Results:

  • HC treatment decreased A431 cell viability and increased apoptosis in a dose-dependent manner.
  • Increased LC3 protein fluorescence indicated enhanced autophagy.
  • Reduced STAT3 protein fluorescence suggested JAK/STAT3 pathway inhibition.
  • HC treatment altered the localization of LC3 and STAT3 proteins.

Conclusions:

  • Hydrazinocurcumin (HC) induces autophagy and apoptosis in A431 cells.
  • HC downregulates the JAK/STAT3 signaling pathway.
  • HC affects A431 cell proliferation, suggesting potential therapeutic applications.
Keywords:
autophagycell proliferationhydrazinocurcumin

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.6K
Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.8K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K